Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1998052542) MEDICINAL AEROSOL PRODUCTS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/052542 International Application No.: PCT/US1998/010155
Publication Date: 26.11.1998 International Filing Date: 18.05.1998
Chapter 2 Demand Filed: 05.11.1998
IPC:
A61K 9/12 (2006.01) ,A61K 31/58 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
12
Aerosols; Foams
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
56
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
58
containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin
Applicants:
MINNESOTA MINING AND MANUFACTURING COMPANY [US/US]; 3M Center P.O. Box 33427 Saint Paul, MN 55133-3427, US (AllExceptUS)
OLIVER, Martin, J. [GB/GB]; GB (UsOnly)
FATANIA, Kanu, M. [GB/GB]; GB (UsOnly)
SCOTT, John, S. [GB/GB]; GB (UsOnly)
MULLER, Helgert [DE/DE]; DE (UsOnly)
Inventors:
OLIVER, Martin, J.; GB
FATANIA, Kanu, M.; GB
SCOTT, John, S.; GB
MULLER, Helgert; DE
Agent:
RINGSRED, Ted, K. ; Minnesota Mining and Manufacturing Company Office of Intellectual Property Counsel P.O. Box 33427 Saint Paul, MN 55133-3427, US
VOSSIUS & PARTNER; P.O. Box 86 07 67 D-81634 München, DE
Priority Data:
9710496.221.05.1997GB
9803990.225.02.1998GB
Title (EN) MEDICINAL AEROSOL PRODUCTS
(FR) PRODUITS MEDICINAUX POUR AEROSOLS
Abstract:
(EN) A pharmaceutical aerosol formulation suitable for oral and/or nasal inhalation including the anti-inflammatory drug ciclesonide, hydrofluorocarbon propellants such as HFC 134a and/or 227, and ethanol in an amount sufficient to solubilize the ciclesonide (and various optional ingredients, such as surfactant). The formulations exhibit very desirable physical and chemical stability, as well as excellent delivery characteristics.
(FR) Composition pharmaceutique pour aérosols, destinée à l'inhalation orale et/ou nasale, comportant du ciclésonide qui est un médicament anti-inflammatoire, des propulseurs de type hydrocarbure fluoré tels que le HFC 134a et/ou 227, et de l'éthanol en quantité suffisante pour solubiliser le ciclésonide (et d'autres ingrédients éventuels, tels qu'un tensioactif). Lesdites compositions possèdent une excellente stabilité physique et chimique, ainsi que d'excellentes caractéristiques d'administration.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CZPV1999-4124NO19995667SK157699TR1999/02863YUP-598/99MXPA/a/1999/010646
KR1020010012810SG68804IL132738EP0983058JP2001526685 CN1257421
CA2290521EA199900991NZ500874AU1998074962DK0983058